Thermo Fisher Scientific is trading 3.42% down at $639.40 on October 8, 2026, with no specific catalyst established. - No reliable report directly attributes the decline to a company-specific event. - The reported $8.9 billion agreement to acquire Clario is recent, but coverage does not link it to the drop. - Markets are softer amid higher yields and oil-related inflation concerns; index moves are modest and healthcare is up, leaving no clear market explanation.